Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 875768, 8 pages
http://dx.doi.org/10.1155/2014/875768
Clinical Study

Determinants of Disability in Multiple Sclerosis: An Immunological and MRI Study

1Unit of Motor Neurorehabilitation, Multiple Sclerosis Center, Fondazione Don Gnocchi, IRCCS Santa Maria Nascente, Via Capecelatro 66, 20148 Milan, Italy
2MR Research Laboratory, Fondazione Don Gnocchi, IRCCS Santa Maria Nascente, Via Capecelatro 66, 20148 Milan, Italy
3Immunology Research Laboratory, Fondazione Don Gnocchi, IRCCS Santa Maria Nascente, Via Capecelatro 66, 20148 Milan, Italy
4Bioengineering Department, Politecnico di Milano, Piazza Leonardo da Vinci, 20133 Milan, Italy
5Epidemiology and Statistics Unit, Fondazione Don Gnocchi, IRCCS Santa Maria Nascente, Via Capecelatro 66, 20148 Milan, Italy
6Department of Epidemiology and Preventive Medicine, University of Regensburg, Regensburg Franz-Josef-Strauß-Allee 11, 93053 Regensburg, Germany

Received 17 January 2014; Revised 12 March 2014; Accepted 17 March 2014; Published 9 April 2014

Academic Editor: Cristoforo Comi

Copyright © 2014 Paola Tortorella et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Kremenchutzky, G. P. A. Rice, J. Baskerville, D. M. Wingerchuk, and G. C. Ebers, “The natural history of multiple sclerosis: a geographically based study 9: observations on the progressive phase of the disease,” Brain, vol. 129, no. 3, pp. 584–594, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. G. S. M. Ramsaransing and J. de Keyser, “Benign course in multiple sclerosis: a review,” Acta Neurologica Scandinavica, vol. 113, no. 6, pp. 359–369, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. A.-L. Sayao, V. Devonshire, and H. Tremlett, “Longitudinal follow-up of “benign” multiple sclerosis at 20 years,” Neurology, vol. 68, no. 7, pp. 496–500, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Rovaris, F. Barkhof, M. Calabrese et al., “MRI features of benign multiple sclerosis Toward a new definition of this disease phenotype,” Neurology, vol. 72, no. 19, pp. 1693–1701, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Calabrese, A. Favaretto, V. Poretto et al., “Low degree of cortical pathology is associated with benign course of multiple sclerosis,” Multiple Sclerosis, vol. 19, pp. 904–911, 2012. View at Google Scholar
  6. S. A. Gauthier, A. M. Berger, Z. Liptak et al., “Rate of brain atrophy in benign vs early multiple sclerosis,” Archives of Neurology, vol. 66, no. 2, pp. 234–237, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Calabrese, V. Poretto, A. Favaretto et al., “Cortical lesion load associates with progression of disability in multiple sclerosis,” Brain, vol. 135, pp. 2952–2961, 2012. View at Google Scholar
  8. N. Shiee, P. L. Bazin, K. M. Zackowski et al., “Revisiting brain atrophy and its relationship to disability in multiple sclerosis,” PLoS ONE, vol. 7, Article ID e37049, 2012. View at Google Scholar
  9. D. M. Harrison, N. Shiee, P. L. Bazin et al., “Tract-specific quantitative MRI better correlates with disability than conventional MRI in multiple sclerosis,” Journal of Neurology, vol. 260, pp. 397–406, 2012. View at Google Scholar
  10. T. Sigal, M. Shmuel, D. Mark, H. Gil, and A. Anat, “Diffusion tensor imaging of corpus callosum integrity in multiple sclerosis: correlation with disease variables,” Journal of Neuroimaging, vol. 22, no. 1, pp. 33–37, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Amedei, D. Prisco, and M. M. D'Elios, “Multiple sclerosis: the role of cytokines in pathogenesis and in therapies,” International Journal of Molecular Sciences, vol. 13, pp. 13438–13460, 2012. View at Google Scholar
  12. T. L. Sørensen and F. Sellebjerg, “Distinct chemokine receptor and cytokine expression profile in secondary progressive MS,” Neurology, vol. 57, no. 8, pp. 1371–1376, 2001. View at Google Scholar · View at Scopus
  13. C. H. Polman, S. C. Reingold, G. Edan et al., “Diagnostic criteria for multiple sclerosis: 2005 revisions to the ‘McDonald Criteria’,” Annals of Neurology, vol. 58, no. 6, pp. 840–846, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. J. F. Kurtzke, “Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS),” Neurology, vol. 33, no. 11, pp. 1444–1452, 1983. View at Google Scholar · View at Scopus
  15. F. D. Lublin and S. C. Reingold, “Defining the clinical course of multiple sclerosis: results of an international survey,” Neurology, vol. 46, no. 4, pp. 907–911, 1996. View at Google Scholar · View at Scopus
  16. M. M. Laganà, A. Ceccarelli, M. G. Preti et al., “Atlas-based versus individual-based fiber tracking of the corpus callosum in patients with multiple sclerosis: reliability and clinical correlations,” Journal of Neuroimaging, vol. 22, pp. 355–364, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. S. M. Smith, N. de Stefano, M. Jenkinson, and P. M. Matthews, “Normalized accurate measurement of longitudinal brain change,” Journal of Computer Assisted Tomography, vol. 25, no. 3, pp. 466–475, 2001. View at Publisher · View at Google Scholar · View at Scopus
  18. K. Hua, J. Zhang, S. Wakana et al., “Tract probability maps in stereotaxic spaces: analyses of white matter anatomy and tract-specific quantification,” NeuroImage, vol. 39, no. 1, pp. 336–347, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. D. S. Reich, A. Ozturk, P. A. Calabresi, and S. Mori, “Automated vs. conventional tractography in multiple sclerosis: Variability and correlation with disability,” NeuroImage, vol. 49, no. 4, pp. 3047–3056, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Saresella, E. Calabrese, I. Marventano et al., “Increased activity of Th-17 and Th-9 lymphocytes and a skewing of the post-thymic differentiation pathway are seen in Alzheimer's disease,” Brain, Behavior, and Immunity, vol. 25, no. 3, pp. 539–547, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. R. A. Fisher, “On the probable error of a coefficient of correlation deduced from a small sample,” Metron, vol. 1, pp. 3–32, 1921. View at Google Scholar
  22. G. Blom, Statistical Estimates and Transformed Beta-Variables, John Wiley & Sons, New York, NY, USA, 1958.
  23. C. Y. Kramer, “Extension of multiple range tests to group means with unequal numbers of replications,” Biometrics, vol. 12, pp. 307–310, 1956. View at Google Scholar
  24. M. Saresella, I. Marventano, F. R. Guerini et al., “Myelin basic protein-specific T lymphocytes proliferation and programmed cell death in demyelinating diseases,” Clinical Immunology, vol. 129, no. 3, pp. 509–517, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. N. Bergsland, D. Horakova, M. G. Dwyer et al., “Subcortical and cortical gray matter atrophy in a large sample of patients with clinically isolated syndrome and early relapsing-remitting multiple sclerosis,” American Journal of Neuroradiology, vol. 33, pp. 1573–1578, 2012. View at Google Scholar
  26. E. Portaccio, M. L. Stromillo, B. Goretti et al., “Neuropsychological and MRI measures predict short-term evolution in benign multiple sclerosis,” Neurology, vol. 73, no. 7, pp. 498–503, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Charil, A. P. Zijdenbos, J. Taylor et al., “Statistical mapping analysis of lesion location and neurological disability in multiple sclerosis: application to 452 patient data sets,” NeuroImage, vol. 19, no. 3, pp. 532–544, 2003. View at Publisher · View at Google Scholar · View at Scopus
  28. K. Hackmack, M. Weygandt, J. Wuerfel et al., “Can we overcome the “clinico-radiological paradox” in multiple sclerosis?” Journal of Neurology, vol. 259, pp. 2151–2160, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. N. Gorgoraptis, C. A. M. Wheeler-Kingshott, T. M. Jenkins et al., “Combining tractography and cortical measures to test system-specific hypotheses in multiple sclerosis,” Multiple Sclerosis, vol. 16, no. 5, pp. 555–565, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. B. Spanò, M. Cercignani, B. Basile et al., “Multiparametric MR investigation of the motor pyramidal system in patients with “truly benign” multiple sclerosis,” Multiple Sclerosis, vol. 16, no. 2, pp. 178–188, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. G. Esendagli, A. T. Kurne, G. Sayat, A. K. Kilic, D. Guc, and R. Karabudak, “Evaluation of Th17-related cytokines and receptors in multiple sclerosis patients under interferon beta-1 therapy,” Journal of Neuroimmunology, vol. 255, pp. 81–84, 2012. View at Google Scholar
  32. M. Rovaris, C. Confavreux, R. Furlan, L. Kappos, G. Comi, and M. Filippi, “Secondary progressive multiple sclerosis: current knowledge and future challenges,” Lancet Neurology, vol. 5, no. 4, pp. 343–354, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. N. Tubridy, A. J. Coles, P. Molyneux et al., “Secondary progressive multiple sclerosis, the relationship between short-term MRI activity and clinical features,” Brain, vol. 121, no. 2, pp. 225–231, 1998. View at Publisher · View at Google Scholar · View at Scopus
  34. L. La Mantia, L. Vacchi, M. Rovaris et al., “Interferon beta for secondary progressive multiple sclerosis: a systematic review,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 84, pp. 420–426, 2012. View at Google Scholar
  35. M. Saresella, F. Piancone, P. Tortorella et al., “T helper-17 activation dominates the immunologic milieu of both amyotrophic lateral sclerosis and progressive multiple sclerosis,” Clinical Immunology, vol. 148, pp. 79–88, 2013. View at Google Scholar
  36. V. Wee Yong, “Inflammation in neurological disorders: a help or a hindrance?” Neuroscientist, vol. 16, no. 4, pp. 408–420, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. M. Penkowa, T. Moos, J. Carrasco et al., “Strongly compromised inflammatory response to brain injury in interleukin-6-deficient mice,” Glia, vol. 25, pp. 343–357, 1999. View at Google Scholar
  38. B. Serafini, B. Rosicarelli, R. Magliozzi, E. Stigliano, and F. Aloisi, “Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis,” Brain Pathology, vol. 14, no. 2, pp. 164–174, 2004. View at Google Scholar · View at Scopus
  39. R. Magliozzi, O. Howell, A. Vora et al., “Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology,” Brain, vol. 130, no. 4, pp. 1089–1104, 2007. View at Publisher · View at Google Scholar · View at Scopus